지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.8
- 수록면
- 1 - 13 (13page)
- DOI
- 10.1038/s12276-020-00494-7
이용수
초록· 키워드
오류제보하기
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with age as a major risk factor. AD is the most common dementia with abnormal structures, including extracellular senile plaques and intraneuronal neurofibrillary tangles, as key neuropathologic hallmarks. The early feature of AD pathology is degeneration of the locus coeruleus (LC), which is the main source of norepinephrine (NE) supplying various cortical and subcortical areas that are affected in AD. The spread of Tau deposits is first initiated in the LC and is transported in a stepwise manner from the entorhinal cortex to the hippocampus and then to associative regions of the neocortex as the disease progresses. Most recently, we reported that the NE metabolite DOPEGAL activates delta-secretase (AEP, asparagine endopeptidase) and triggers pathological Tau aggregation in the LC, providing molecular insight into why LC neurons are selectively vulnerable to developing early Tau pathology and degenerating later in the disease and how δ-secretase mediates the spread of Tau pathology to the rest of the brain. This review summarizes our current understanding of the crucial role of δ-secretase in driving and spreading AD pathologies by cleaving multiple critical players, including APP and Tau, supporting that blockade of δ-secretase may provide an innovative disease-modifying therapeutic strategy for treating AD.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
γ-Secretase in Alzheimer’s disease
Experimental and Molecular Medicine
2022 .04
-
Degradation or aggregation: the ramifications of post-translational modifications on tau
BMB Reports
2018 .01
-
FGFR3 drives Aβ-induced tau uptake
Experimental and Molecular Medicine
2024 .07
-
Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice
Experimental and Molecular Medicine
2023 .03
-
Label-Free Fluorescence Lifetime Imaging of Amyloid-Beta and Tau Fibrils in Alzheimer’s Disease Cerebral Organoid Models
한국생물공학회 학술대회
2023 .10
-
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain
Experimental and Molecular Medicine
2018 .01
-
Amelioration of Taupathy via Suppression of Tau Hyperphosphorylation by Reducing the Expression Level of Various Involved Genes and Kinesis with Theasaponin E1, a Therapeutic Target for Alzheimer’s Treatment
한국생물공학회 학술대회
2021 .04
-
Characterization of a New Anti-dementia β-secretase Inhibitory Peptide from Arctoscopus japonicus
Journal of Chitin and Chitosan
2018 .01
-
Amelioration of Tauopathy via Suppression of Tau Hyperphosphorylation by Reducing the Expression Level of Various Involved Genes and Kinesis with Theasaponin E1, A Therapeutic Target for Alzheimer’s Treatment
한국생물공학회 학술대회
2021 .10
-
Tau mis-splicing in the pathogenesis of neurodegenerative disorders
BMB Reports
2016 .01
-
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease
BMB Reports
2019 .01
-
Recent Advances in Photoelectrochemical Sensing of Alzheimer’s Biomarkers
BioChip Journal
2023 .06
-
생성적 적대 신경망 기반의 3D 뇌 영상을 이용한 알츠하이머 질병 예측 모델
대한전자공학회 학술대회
2023 .06
-
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
Experimental and Molecular Medicine
2019 .01
-
β-secretase Inhibitory Effects of Metanolic Extracts from Euphorbiaceae and Leguminosae against Alzheimer"s Disease
한국생물공학회 학술대회
2015 .10
-
New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
Experimental and Molecular Medicine
2020 .01
-
Green Tea Seed Isolated Saponins Attenuate Tau Hyperphosphorylation in SHY-5Y Cells by Downregulation of the Associated Kinases and Upregulation of Phosphatases in the Tau Phosphorylation Signaling Pathway
한국생물공학회 학술대회
2020 .06
-
Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review
BMB Reports
2020 .01
-
멀티오믹스 데이터를 활용한 알츠하이머 질병 예측 딥러닝 모델 개발 연구
한국정보기술학회논문지
2022 .07
-
Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease
Experimental and Molecular Medicine
2023 .05
이 논문의 저자 정보
최근 본 자료
댓글(0)
0